Categories
CURRENT TRIALS TRIAL

Suffering from  Moderate to Severe Hidradenitis Suppurativa?

Suffering from  Moderate to Severe Hidradenitis Suppurativa?

Trial – Acrotech

Incyte is conducting a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of XXXXXXXXX in Participants with Moderate to Severe Hidradenitis Suppurativa

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  INCB- 54707-301

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Mild to Moderate Atopic Dermatitis?

Suffering from Mild to Moderate Atopic Dermatitis?

Trial – Acrotech

Acrotech is conducting an Open-label Study to Assess the Long-Term Safety of XXXXXXXX Ointment in Mild to Moderate Atopic Dermatitis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # MEDI-MM36-302

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Nail and Scalp Psoriasis?

Suffering from Nail and Scalp Psoriasis?

Trial – Eli Lilly

Eli Lilly is conducting a US-Based Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated with Ixekizumab (Taltz)

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  I1F-MC-B018

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Atopic Dermatitis with Skin of Color?

Suffering from Atopic Dermatitis with Skin of Color?

Trial – Eli Lilly

Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBP

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Previously Treated With Dupilumab for Atopic Dermatitis?

Previously Treated With Dupilumab for Atopic Dermatitis?

Trial – Eli Lilly

Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBO

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
PREVIOUS TRIALS

Suffering from Chronic Hives?

Suffering from Chronic Hives?

Suffering from chronic hives?

Trial – AMGEN/IQVIA

Suffering from Chronic Hives?

A 32-week Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging, Phase 2b Study to Evaluate Efficacy and Safety of xxxxxxxxxx for the Treatment of Chronic Spontaneous Urticaria

Males and Females between the ages of 18-80 may qualify.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # 20190194

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Suffering from Atopic Dermatitis?

Suffering from Atopic Dermatitis?

Trial – Syneos Health/Eli Lilly

Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe Atopic Dermatitis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-DM-KGAA/DRM06-AD07

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
PREVIOUS TRIALS

Nail Psoriasis XXXXXXXXX Treatment Study

Nail Psoriasis XXXXXXXXX Treatment Study

Trial – Sun Pharma | IQVIA

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy and Safety of XXXXXXXXX in the Treatment of Moderate to Severe Nail Psoriasis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #TILD-18-19

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
PREVIOUS TRIALS TRIAL

XXXX XXXXXXX for Pediatric Psoriasis

XXXX XXXXXXX for Pediatric Psoriasis

Trial – Amgen | PPD

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XXXXXXX (CC-10004) in Pediatric Subjects from 6 Through 17 Years of Age with Moderate to Severe Plaque Psoriasis.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.

Categories
CURRENT TRIALS TRIAL

Hidradenitis Suppurativa Treatment Extension Study

Hidradenitis Suppurativa Treatment Extension Study

Trial –Novartis

A multicenter, double-blind, randomized withdrawal extension study of subcutaneous XXXXXXXXXX to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe hidradenitis suppurativa.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # CAIN457M2301E1

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.